fluoxetine has been researched along with 9-(tetrahydro-2-furyl)-adenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosmans, E; De Baets, M; Kenis, G; Kubera, M; Maes, M; Steinbusch, H | 1 |
| Clapp, LH; Fry, CH; Orie, NN | 1 |
2 other study(ies) available for fluoxetine and 9-(tetrahydro-2-furyl)-adenine
| Article | Year |
|---|---|
The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adult; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Fluoxetine; Humans; Immunosuppressive Agents; In Vitro Techniques; Interferon-gamma; Interleukin-10; Lipopolysaccharides; Male; Protein Kinase Inhibitors; Signal Transduction; Thionucleotides; Tumor Necrosis Factor-alpha | 2005 |
Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Apamin; Barium Compounds; Charybdotoxin; Chlorides; Cromakalim; Cyclic AMP; DDT; Dose-Response Relationship, Drug; Epoprostenol; Fluoxetine; Glyburide; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neurotoxins; Phenylephrine; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Vasodilator Agents | 2006 |